Inventor profile of:

Ernst WEBER

City:

Langenfeld

Country:

Germany

Published Applications:

23

Last publication date:

2025-11-27

Top Assignees for applications by Ernst WEBER

The entities that hold a legal rights for patent applications filed by inventor WEBER Ernst:

Recent patent applications by WEBER Ernst

Ernst WEBER from Langenfeld, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-11-27
US20250361282A1
Chemistry; metallurgy

ATRIAL NATRIURETIC PEPTIDE ENGRAFTED ANTIBODIES

#2 | 2025-06-12
US20250188189A1
Chemistry; metallurgy

HUMAN ANTIBODIES AGAINST ACTIVATED PROTEIN C AND USES THEREOF

#3 | 2024-12-05
US20240400700A1
Chemistry; metallurgy

CCR8 ANTIBODIES FOR THERAPEUTIC APPLICATIONS

#4 | 2024-11-14
US20240376218A1
Chemistry; metallurgy

CCR8 ANTIBODIES FOR THERAPEUTIC APPLICATIONS

#5 | 2024-09-26
US20240317847A1
Chemistry; metallurgy

INHIBITORS OF IL-11 OR IL-11Ra FOR USE IN THE TREATMENT OF ABNORMAL UTERINE BLEEDING

#6 | 2024-08-01
US20240254222A1
Chemistry; metallurgy

Anti-sema3a antibodies and uses thereof

#7 | 2024-05-23
US20240166766A1
Chemistry; metallurgy

Anti-A2AP antibodies and uses thereof

#8 | 2024-04-18
US20240124572A1
Chemistry; metallurgy

INHIBITORS OF IL-11 OR IL-11Ra FOR USE IN THE TREATMENT OF ABNORMAL UTERINE BLEEDING

#9 | 2024-02-01
US20240034810A1
Chemistry; metallurgy

ANTI-A2AP ANTIBODIES AND USES THEREOF

#10 | 2024-01-11
US20240010750A1
Chemistry; metallurgy

NOVEL ANTI-A2AP ANTIBODIES AND USES THEREOF

#11 | 2023-08-10
US20230250178A1
Chemistry; metallurgy

SULFATED PEPTIDES FOR CHEMOKINE RECEPTOR ANTIBODY GENERATION

#12 | 2022-12-08
US20220389096A1
Chemistry; metallurgy

NOVEL ANTI-SEMA3A ANTIBODIES AND USES THEREOF

#13 | 2022-11-17
US20220363768A1
Chemistry; metallurgy

Methods of treatment using CCR8 antibodies

#14 | 2022-06-16
US20220185901A1
Chemistry; metallurgy

Bispecific antibodies binding ALK-1 and BMPR-2

#15 | 2021-12-23
US20210395390A1
Chemistry; metallurgy

REVERSAL AGENTS FOR NEUTRALIZING THE THERAPEUTIC ACTIVITY OF ANTI-FXIA ANTIBODIES

#16 | 2021-05-13
US20210139555A1
Chemistry; metallurgy

ATRIAL NATRIURETIC PEPTIDE ENGRAFTED ANTIBODIES

#17 | 2020-10-22
US20200332013A1
Chemistry; metallurgy

Bispecific antibodies binding ALK-1 and BMPR-2

#18 | 2020-07-30
US20200239905A1
Chemistry; metallurgy

HPPD variants and methods of use

#19 | 2020-05-07
US20200138970A1
Human necessities

Antibody drug conjugates of kinesin spindel protein (KSP) inhibitors with antiB7H3-antibodies

#20 | 2020-02-27
US20200063155A1
Chemistry; metallurgy

HPPD variants and methods of use

#21 | 2019-10-03
US20190298865A1
Human necessities

RADIO-PHARMACEUTICAL COMPLEXES

#22 | 2018-07-26
US20180208937A1
Chemistry; metallurgy

HPPD variants and methods of use

#23 | 2018-07-05
US20180185510A1
Human necessities

ANTIBODY DRUG CONJUGATES OF KINESIN SPINDEL PROTEIN (KSP) INHIBITORS WITH ANTI-B7H3-ANTIBODIES

InventorID:

2232190 ⎘